During the past decade, Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie" are "Aspergillosis" (1 trials) and "Candidiasis" (1 trials). Many other conditions were trialed in "Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie" in a lesser frequency.

Most popular intervention types in "Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "FK463" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".